March 17 (Reuters) -
Innate Immunotherapeutics Ltd IIL.AX :
* Has resolved to make a private placement to raise gross proceeds of a$2mln
* Intends to use proceeds for additional working capital beyond planned release of phase 2b trial results in q3 of 2017
* Placement of 2.8 million ordinary shares will be priced at a$0.72 per share
Source text for Eikon: ID:nASX6WQwVz
Further company coverage: IIL.AX